🇺🇸 FDA
Pipeline program

High-Low Dose Radiotherapy

REDEFINE

Phase 2 other active

Quick answer

High-Low Dose Radiotherapy for Nasopharyngeal Carcinoma (NPC) is a Phase 2 program (other) at Jian Li with 1 ClinicalTrials.gov record(s).

Program details

Company
Jian Li
Indication
Nasopharyngeal Carcinoma (NPC)
Phase
Phase 2
Modality
other
Status
active

Clinical trials